NTBC treatment in tyrosinaemia type I: long-term outcome in French patients.

Masurel-Paulet, A; Poggi-Bach, J; Rolland, M-O; Bernard, O; Guffon, N; Dobbelaere, D; Sarles, J; de Baulny, H Ogier; Touati, G

Masurel-Paulet, A; Poggi-Bach, J; Rolland, M-O; Bernard, O; Guffon, N; Dobbelaere, D; Sarles, J; de Baulny, H Ogier; Touati, G.

Affiliation

Masurel-Paulet A; Pediatric Department, Hôpital d'Enfants, Dijon, France.

J Inherit Metab Dis ; 31(1): 81-7, 2008 Feb.

Article in En | MEDLINE | ID: mdl-18214711

Subject(s)

Cyclohexanones/therapeutic use; Nitrobenzoates/therapeutic use; Tyrosinemias/drug therapy; Child, Preschool; Cyclohexanones/adverse effects; Enzyme Inhibitors/adverse effects; Enzyme Inhibitors/therapeutic use; Follow-Up Studies; France; Humans; Infant; Infant, Newborn; Liver/physiology; Liver Function Tests; Nitrobenzoates/adverse effects; Patient Compliance; Retrospective Studies; Time Factors; Treatment Failure; Tyrosinemias/physiopathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Tyrosinemias / Cyclohexanones / Nitrobenzoates Type of study: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child, preschool / Humans / Infant / Newborn Country/Region as subject: Europa Language: En Year: 2008 Type: Article

Fulltext

XML

PubMed Links

Search on Google